{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:01:52Z","timestamp":1761058912828},"reference-count":14,"publisher":"Cambridge University Press (CUP)","issue":"1","license":[{"start":{"date-parts":[[2009,3,10]],"date-time":"2009-03-10T00:00:00Z","timestamp":1236643200000},"content-version":"unspecified","delay-in-days":4817,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Technol Assess Health Care"],"published-print":{"date-parts":[[1996]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Economic evaluations of Pharmaceuticals are increasingly being conducted in conjunction with randomized phase III clinical trials to meet the demand for pharmacoeconomic data when new products are launched. While the need for such data is often global, the trials in which relevant information may be collected are often conducted in only one or a limited number of countries. A critical issue is how data from pivotal clinical trials in one setting can serve as the basis for pharmacoeconomic evaluations in others. We address this issue and report on four economic evaluations that we undertook in conjunction with a recent U.S. phase III clinical trial of recombinant human deoxyribonuclease (rhDNase), which is used to improve pulmonary function in patients with cystic fibrosis (CF). The objective of these evaluations was to estimate the potential impact of rhDNase therapy in France, Germany, Italy, and the United Kingdom on the direct costs of medical care for the treatment of respiratory tract infections (RTIs) in patients with CF. Analyses of economic impact were undertaken<\/jats:p>","DOI":"10.1017\/s0266462300009387","type":"journal-article","created":{"date-parts":[[2009,3,10]],"date-time":"2009-03-10T11:37:54Z","timestamp":1236685074000},"page":"52-61","source":"Crossref","is-referenced-by-count":33,"title":["A Multinational Economic Evaluation of rhDNase in the Treatment of Cystic Fibrosis"],"prefix":"10.1017","volume":"12","author":[{"given":"Joseph","family":"Menzin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerry","family":"Oster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Davies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael F.","family":"Drummond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Greiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Lucioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Louis","family":"Merot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franco","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Graf","family":"Schulenburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Sou\u00eatre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2009,3,10]]},"reference":[{"key":"S0266462300009387_ref010","first-page":"155","volume-title":"National accounts, vol. 1: Main aggregates, 1960\u201392","year":"1994"},{"key":"S0266462300009387_ref012","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)92297-7"},{"key":"S0266462300009387_ref004","doi-asserted-by":"publisher","DOI":"10.1002\/hec.4730010202"},{"key":"S0266462300009387_ref014","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.87.23.9188"},{"key":"S0266462300009387_ref013","first-page":"1","volume-title":"Reglementation, Monatsliste, abed Spezialitdten Nachtrag zum Katalog","year":"1994"},{"key":"S0266462300009387_ref009","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199409083311003"},{"key":"S0266462300009387_ref008","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(05)83478-X"},{"key":"S0266462300009387_ref007","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(84)90118-1"},{"key":"S0266462300009387_ref003","volume-title":"Annual data report, 1991","year":"1992"},{"key":"S0266462300009387_ref002","volume-title":"Guidelines for the submission of data to the Pharmaceutical Benefits Advisory Committee (PBAC) including economic analysis","year":"1992"},{"key":"S0266462300009387_ref005","doi-asserted-by":"publisher","DOI":"10.1017\/S0266462300002361"},{"key":"S0266462300009387_ref011","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/148.1.145"},{"key":"S0266462300009387_ref006","doi-asserted-by":"publisher","DOI":"10.1017\/S0266462300007121"},{"key":"S0266462300009387_ref001","unstructured":"1. Anders G. Doubts are cast on cost studies by drug makers. Wall Street Journal, 06 28, 1994, section B, 1."}],"container-title":["International Journal of Technology Assessment in Health Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0266462300009387","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T19:52:58Z","timestamp":1557777178000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0266462300009387\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1996]]}},"alternative-id":["S0266462300009387"],"URL":"https:\/\/doi.org\/10.1017\/s0266462300009387","relation":{},"ISSN":["0266-4623","1471-6348"],"issn-type":[{"value":"0266-4623","type":"print"},{"value":"1471-6348","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996]]}}}